Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters











Database
Language
Publication year range
1.
CNS Neurosci Ther ; 29(1): 331-343, 2023 01.
Article in English | MEDLINE | ID: mdl-36353757

ABSTRACT

AIMS: Resistance to valproic acid (VPA) is a major challenge for epilepsy treatment. We aimed to explore the mechanism underlying this resistance. METHODS: Pentylenetetrazol-induced chronic epileptic rats were administered VPA (250 mg/Kg) for 14 days; rats with controlled seizure stages (seizure score14th-before ≤0) and latent time (latent time14th-before ≥0) were considered VPA-responsive, while the others were considered nonresponsive. Differentially expressed genes (DEGs) between the VPA-responsive and nonresponsive rat hippocampus transcriptomes were identified, and their functions were evaluated. The roles of postsynaptic density (PSD) and Homer1 were also determined. Furthermore, a subtype of Homer1 (Homer1b/c) was overexpressed or silenced in HT22 cells to determine its effect on VPA efficacy. Moreover, the membrane levels of mGluR1/5 directly bound to Homer1b/c were assessed. RESULTS: Overall, 264 DEGs commonly enriched in the PSD between VPA-responsive and nonresponsive rats. Among them, Homer1 was more highly expressed in the hippocampus of nonresponses compared to that of responses. Overexpression of Homer1b/c interrupted VPA efficacy by increasing reactive oxygen species production, lactate dehydrogenase release, and calcium content. Furthermore, it induced the overexpression of mGluR1 and mGluR5. CONCLUSION: Overexpression of Homer1b/c influenced VPA efficacy, revealing it could be a target to improve the efficacy of this treatment.


Subject(s)
Epilepsy , Valproic Acid , Animals , Rats , Anticonvulsants , Epilepsy/chemically induced , Epilepsy/drug therapy , Epilepsy/genetics , Pentylenetetrazole , Receptor, Metabotropic Glutamate 5/therapeutic use , Seizures/drug therapy , Valproic Acid/therapeutic use , Mice
2.
Psychiatry Res ; 260: 152-157, 2018 02.
Article in English | MEDLINE | ID: mdl-29195167

ABSTRACT

The D2 receptor partial agonist, aripiprazole, has shown increased therapeutic efficacy for schizophrenia, autism and Tourette's syndrome compared to traditional antipsychotics such as the D2 receptor antagonist, haloperidol. Recent evidence suggests this superior profile may be associated with downstream effects on glutamatergic synapses. Group 1 metabotropic glutamate receptors (mGluRs) and their endogenous modulators, Norbin and Homer1, are regulated by D2 receptor activity, particularly within the nucleus accumbens (NAc), a target region of aripiprazole and haloperidol. This study sought to evaluate the effects of aripiprazole on Group 1 mGluRs, Norbin and Homer1 in the NAc, in comparison to haloperidol. Sprague-Dawley rats were orally administered daily doses of aripiprazole (2.25mg/kg), haloperidol (0.3mg/kg) or vehicle for 1 or 10-weeks. Immunoblot analyses revealed Group 1 mGluR protein levels were not altered following 1-week and 10-week aripiprazole or haloperidol treatment, compared to vehicle treated rodents. However, 1-week aripiprazole and haloperidol treatment significantly elevated Homer1a and Norbin protein expression, respectively. After 10 weeks of treatment, aripiprazole, but not haloperidol, significantly increased Norbin expression. These findings indicate the antipsychotics, aripiprazole and haloperidol, exert differential temporal effects on Norbin and Homer1 expression that may have consequences on synaptic glutamatergic transmission underlying their therapeutic profile.


Subject(s)
Antipsychotic Agents/pharmacology , Aripiprazole/pharmacology , Haloperidol/pharmacology , Nucleus Accumbens/drug effects , Receptors, Metabotropic Glutamate/drug effects , Animals , Antipsychotic Agents/administration & dosage , Aripiprazole/administration & dosage , Haloperidol/administration & dosage , Male , Rats , Rats, Sprague-Dawley
3.
Elife ; 62017 01 30.
Article in English | MEDLINE | ID: mdl-28134614

ABSTRACT

SNX6 is a ubiquitously expressed PX-BAR protein that plays important roles in retromer-mediated retrograde vesicular transport from endosomes. Here we report that CNS-specific Snx6 knockout mice exhibit deficits in spatial learning and memory, accompanied with loss of spines from distal dendrites of hippocampal CA1 pyramidal cells. SNX6 interacts with Homer1b/c, a postsynaptic scaffold protein crucial for the synaptic distribution of other postsynaptic density (PSD) proteins and structural integrity of dendritic spines. We show that SNX6 functions independently of retromer to regulate distribution of Homer1b/c in the dendritic shaft. We also find that Homer1b/c translocates from shaft to spines by protein diffusion, which does not require SNX6. Ablation of SNX6 causes reduced distribution of Homer1b/c in distal dendrites, decrease in surface levels of AMPAR and impaired AMPAR-mediated synaptic transmission. These findings reveal a physiological role of SNX6 in CNS excitatory neurons.


Subject(s)
CA1 Region, Hippocampal/physiology , Pyramidal Cells/physiology , Sorting Nexins/deficiency , Spatial Memory , Synapses/physiology , Animals , Homer Scaffolding Proteins/metabolism , Mice, Knockout , Receptors, Glutamate/metabolism , Sorting Nexins/metabolism
4.
Int J Mol Sci ; 17(12)2016 Dec 17.
Article in English | MEDLINE | ID: mdl-27999308

ABSTRACT

BACKGROUND: Mutations in the Cu/Zn superoxide dismutase (SOD1) gene have been linked to amyotrophic lateral sclerosis (ALS). However, the molecular mechanisms have not been elucidated yet. Homer family protein Homer1b/c is expressed widely in the central nervous system and plays important roles in neurological diseases. In this study, we explored whether Homer1b/c was involved in SOD1 mutation-linked ALS. RESULTS: In vitro studies showed that the SOD1 G93A mutation induced an increase of Homer1b/c expression at both the mRNA and protein levels in NSC34 cells. Knockdown of Homer1b/c expression using its short interfering RNA (siRNA) (si-Homer1) protected SOD1 G93A NSC34 cells from apoptosis. The expressions of Homer1b/c and apoptosis-related protein Bax were also suppressed, while Bcl-2 was increased by lithium and valproic acid (VPA) in SOD1 G93A NSC34 cells. In vivo, both the mRNA and protein levels of Homer1b/c were increased significantly in the lumbar spinal cord in SOD1 G93A transgenic mice compared with wild type (WT) mice. Moreover, lithium and VPA treatment suppressed the expression of Homer1b/c in SOD1 G93A mice. CONCLUSION: The suppression of SOD1 G93A mutation-induced Homer1b/c upregulation protected ALS against neuronal apoptosis, which is a novel mechanism of the neuroprotective effect of lithium and VPA. This study provides new insights into pathogenesis and treatment of ALS.


Subject(s)
Amyotrophic Lateral Sclerosis/therapy , Homer Scaffolding Proteins/biosynthesis , Lithium/therapeutic use , Superoxide Dismutase/genetics , Valproic Acid/therapeutic use , Amyotrophic Lateral Sclerosis/genetics , Amyotrophic Lateral Sclerosis/pathology , Animals , Apoptosis/genetics , Cell Line , Genetic Predisposition to Disease , Homer Scaffolding Proteins/antagonists & inhibitors , Homer Scaffolding Proteins/genetics , Humans , Mice , Mice, Transgenic , Proto-Oncogene Proteins c-bcl-2/metabolism , RNA Interference , RNA, Small Interfering/genetics
5.
Neurosci Lett ; 559: 88-93, 2014 Jan 24.
Article in English | MEDLINE | ID: mdl-24316406

ABSTRACT

Previous studies have shown that spinal Homer 1b/c plays an important role in the maintenance of chronic inflammatory pain induced by complete Freund's adjuvant (CFA). This study investigated the possible mechanism underlying Homer 1b/c mediating CFA-induced inflammatory pain. Chronic inflammation was induced by CFA injection into the left hind ankle of the rat. Homer 1b/c antisense or missense oligonucleotides were administered intrathecally (10µg/10µl) from 5 to 8 days following the onset of inflammation. Immunohistochemistry was conducted to detect the expression of phosphorylated cAMP response element binding protein (pCREB) and Fos protein in the spinal dorsal horn. Intrathecal administration of Homer 1b/c antisense oligonucleotides not only markedly reduced the expression of Homer 1b/c protein, but also attenuated CFA-induced inflammation, spinal CREB phosphorylation, and Fos expression. These results demonstrate for the first time that Homer 1b/c regulates CREB phosphorylation and c-fos activation in the spinal dorsal horn during the maintenance of chronic inflammatory pain, suggesting that Homer 1b/c may be involved in the development of CFA-induced inflammation.


Subject(s)
Carrier Proteins/administration & dosage , Cyclic AMP Response Element-Binding Protein/metabolism , Genes, fos/physiology , Pain/metabolism , Spinal Cord/metabolism , Synapses/metabolism , Animals , Carrier Proteins/physiology , Chronic Pain , Genes, fos/drug effects , Homer Scaffolding Proteins , Inflammation/metabolism , Inflammation/pathology , Injections, Spinal , Male , Pain/pathology , Phosphorylation/drug effects , Phosphorylation/physiology , Rats , Rats, Wistar , Spinal Cord/drug effects , Spinal Cord/pathology , Synapses/drug effects , Synapses/pathology
SELECTION OF CITATIONS
SEARCH DETAIL